Star Bulk Carriers Corp. Announces Delivery of Three Capesize Vessels
Star Bulk Carriers Corp. a global shipping company focusing on the transportation of dry bulk cargoes announced today that it has taken delivery of the three capesize vessels E.R. BAYONNE, E.R. BUENOS AIRES and E.R. BORNEO (the “Vessels”) from entities affiliated with E.R. Capital Holding GmbH & Cie. KG (“E.R.” or “Sellers”), pursuant to the transaction previously disclosed on December 17, 2020. The Cash Consideration of the transaction was financed through proceeds of a new five-year term loan from a leading European financial institution.
Following these deliveries, the Company has 99,239,716 common shares issued and outstanding.
Great Southern Bancorp, Inc. Reports Preliminary Fourth Quarter and Annual Earnings of $1.28 and $4.21 Per Diluted Common Share Great Southern Bancorp, Inc.
Preliminary Financial Results and Other Matters for the Quarter and Year Ended December 31, 2020:
CECL Adoption: The recently-enacted COVID relief legislation, the Consolidated Appropriations Act, 2021, provides for an optional additional delay for certain bank holding companies to adopt the Current Expected Credit Loss (CECL) accounting standard. Great Southern Bancorp, Inc. (the Company) has elected to delay the initial adoption date of this standard to January 1, 2021, in accordance with guidance approved by the Securities and Exchange Commission. Therefore, the Company’s financial statements for the three months and year ended December 31, 2020, were prepared under the existing incurred loss accounting standard. The adoption of the CECL model during the first quarter of 2021 will require us to recognize a one-time c
BridgeBio Pharma, Inc. Prices Upsized Offering of $650 Million Convertible Senior Notes
January 25, 2021 23:04 ET | Source: BridgeBio Pharma, Inc. BridgeBio Pharma, Inc. Palo Alto, California, UNITED STATES
PALO ALTO, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the “Company,” “we” or “BridgeBio”) announced today the pricing of $650 million aggregate principal amount of 2.25% convertible senior notes due 2029 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering of $400 million aggregate principal amount of notes. In connection with the offering, the Company granted the initial purchasers an option to purchase up to an additional $97.5 million aggregate principal amount of notes. The s
Calliditas Therapeutics launches proposed global offering
News provided by
Share this article
Calliditas Therapeutics AB (publ) ( Calliditas ) (Nasdaq OMX: CALTX) (Nasdaq: CALT)
will today launch a proposed public offering of American Depositary Shares ( ADSs ), in the United States for trading on The Nasdaq Global Select Market in the United States (the U.S. Offering ) and a concurrent private placement of common shares to certain qualified investors in Europe and other countries outside of the United States (the Private Placement , and together with the U.S. Offering, the Global Offering ). The target size of the Global Offering is 4,500,000 common shares plus a potential 30-day over-allotment option of 15 percent of the common shares (including common shares in the form of ADSs) offered by Calliditas at the U.S. Offering price. The Global Offering is subject to market conditions and investor demand and the number of ADSs (which represents two common shares) and common shar
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BJ’s Restaurants, Inc. Announces At-The-Market Equity Offering Program
BJ s Restaurants, Inc.January 22, 2021 GMT
HUNTINGTON BEACH, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) BJ’s Restaurants, Inc. (NASDAQ: BJRI) today announced that it is filing a prospectus supplement with the Securities and Exchange Commission (“SEC”), under which the Company may, from time to time, offer and sell shares of its common stock (the “Shares”) having an aggregate offering price of up to $25,000,000 through an “at-the-market” equity offering program (the “ATM Program”). The Company currently intends to use the net proceeds from sales of Shares under the ATM Program for working capital and other general corporate purposes, including capital expenditures and new restaurant expansion, as well as to strengthen our balance sheet. The timing of any sales under the ATM Program will depend on a va